スポンサーリンク
Clinical Research Center, National Nagasaki Medical Center | 論文
- Semi-quantitative discrimination of HBV mutants using allele-specific oligonucleotide hybridization with Handy Bio-Strand(METHODS)
- Semi-quantitative discrimination of HBV mutants using allele-specific oligonucleotide hybridization with Handy Bio-Strand
- Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC) : The HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC
- The Significance of Enzyme Immunoassay for the Assessment of Hepatitis B Virus Core-Related Antigen following Liver Transplantation
- Human intrahepatic biliary epithelial cell as possible modulator of hepatic regeneration : Potential role of biliary epithelial cell for hepatic remodeling in vivo
- Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging : Long term trends in Japan
- Effects of naturally occurring mutations in hepatitis B virus core promoter on transcriptional activity
- Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis
- Analysis of interferon regulatory factor 1 and 2 gene expression in human hepatoma cell lines
- Pancreatic Carcinogenesis : Apoptosis and Angiogenesis
- Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
- Efficacy of early retreatment with interferon β for relapse in patients with genotype Ib chronic hepatitis C
- Pilot study of prolonged interferon-α retreatment in chronic hepatitis C patients with genotype 1b
- A pediatric patient with acute hepatitis E in Japan
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Autoimmune Pancreatitis with Primary Sclerosing Cholangitis-like Lesion
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus